This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocialmodel, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. More aware of a need for humility.
On the one hand, the biopsychosocialmodel is the most proliferated, which in theory acknowledges psychological and societal factors alongside biological ones, but slapping these three domains together within one model does little to elucidate the interplay between them.
In Part 1 , we discussed Mad in America, the biopsychosocialmodel and the history of psychiatry. Was it related to medical insurance or government programs? The minute that the APA published DSM-III, they had to sell this new model of thinking to the public, and they launched a big PR effort with money from the drug companies.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content